Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/19135
Title: Calretinin but not caveolin-1 correlates with tumour histology and survival in malignant mesothelioma.
Authors: Thapa, Bibhusal;Walkiewicz, Marzena;Murone, Carmel;Asadi, Khashayar;Deb, Siddhartha;Barnett, Stephen A;Knight, Simon R;Mitchell, Paul L R;Liew, Danny;Watkins, D Neil;John, Thomas
Affiliation: Anatpath, Gardenvale, Vic, Australia
School of Cancer Medicine, La Trobe University, Vic, Australia
Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
Department of Pathology, Austin Health, Heidelberg, Victoria, Australia
Department of Thoracic Surgery, Austin Health, Heidelberg, Victoria, Australia
Department of Medical Oncology, Austin Health, Olivia-Newton John Cancer and Wellness Centre, Heidelberg, Victoria, Australia
Department of Epidemiology and Preventive Medicine, Monash University, Vic, Australia
Garvan Institute of Medical Research, NSW, Australia
Department of Medicine, University of Melbourne, Vic, Australia
Issue Date: Dec-2016
EDate: 2016-10-22
Citation: Pathology 2016; 48(7): 660-665
Abstract: Malignant mesothelioma (MM) continues to be a disease with poor prognosis and limited treatment options. Calretinin and caveolin-1 expression by tumour in MM have recently been described to be associated with tumour histology, differentiation and consequently survival. In a large, well annotated cohort, we studied both of these biomarkers and explored their association with clinicopathological parameters and survival. A retrospective search of patients with MM who underwent surgery at the Austin Hospital in Melbourne, Australia, was conducted. Clinical history and outcome data were retrieved from patient records. Tissue microarrays (TMAs) were constructed and stained for calretinin and caveolin-1. 'H scores' were derived, taking intensity and distribution of staining, and the cohort was dichotomised using median values for both markers. In the 329 patients evaluated, median age was 67 years. Males outnumbered females by 5:1. Epithelioid histology 202/319 (62.9%) was the most common, followed by biphasic 72/319 (21.8%) and sarcomatoid 45/319 (13.6%); histology could not be confirmed in 10 patients. Calretinin expression was detected in 246 of the 324 (76%) evaluable patients and high expression was associated with epithelioid histology (p < 0.0001). Caveolin-1 was expressed in 298 (94%) of 317 evaluable patients which was much higher compared to its expression in a cohort of lung adenocarcinomas (8/58, 13.7%). However, no association with histology was found (p = 0.409). When taken as a continuous variable, calretinin expression was found to be an independent predictor of survival, alongside histology, neutrophil-lymphocyte ratio, weight loss and stage. No prognostic value was demonstrable for caveolin-1 expression and calretinin/caveolin-1 ratio. There was no relationship between calretinin and caveolin-1 expression. In MM, increased calretinin expression is associated with epithelioid histology and better survival. Caveolin-1 is a sensitive MM marker and is expressed in a high proportion of cases but lacks association with histology and survival.
URI: http://ahro.austin.org.au/austinjspui/handle/1/19135
DOI: 10.1016/j.pathol.2016.08.003
PubMed URL: 27780599
Type: Journal Article
Subjects: Calretinin
caveolin-1
immunohistochemistry
mesothelioma
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.